1. Insulin-Like Growth Factor and Epidermal Growth Factor Signaling in Breast Cancer Cell Growth: Focus on Endocrine Resistant Disease
   Kallirroi Voudouri et al, 2015, Analytical Cellular Pathology CrossRef
2. Molecular Signatures Associated with Treatment of Triple-Negative MDA-MB231 Breast Cancer Cells with Histone Deacetylase Inhibitors JAHA and SAHA
   Mariangela Librizzi et al, 2017, Chemical Research in Toxicology CrossRef
3. NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings
   Matteo Centonze et al, 2018, Translational Oncology CrossRef
4. A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics
   Salvador Harguindey et al, 2020, International Journal of Molecular Sciences CrossRef
5. Phosphorylation of NHERF1 S279 and S301 differentially regulates breast cancer cell phenotype and metastatic organotropism
   Maria Raffaella Greco et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
6. Mining for Candidate Genes Related to Pancreatic Cancer Using Protein-Protein Interactions and a Shortest Path Approach
   Fei Yuan et al, 2015, BioMed Research International CrossRef
7. Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era
   Salvador Harguindey et al, 2020, International Journal of Molecular Sciences CrossRef
8. Alteration in the sensitivity to crizotinib by Na+/H+ exchanger regulatory factor 1 is dependent to its subcellular localization in ALK-positive lung cancers
   Fenglian Yang et al, 2020, BMC Cancer CrossRef
9. Designing a novel high-throughput AlphaLISA assay to quantify plasma NHERF1 as a non-small cell lung cancer biomarker
   Guifang Du et al, 2015, RSC Advances CrossRef
10. GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling
    Xiyin Li et al, 2021, Cancer Letters CrossRef
11. Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma
    Xinfang Mao et al, 2017, Oncotarget CrossRef
12. Design, Synthesis and Anticancer Evaluation of Novel Quinazoline-Sulfonamide Hybrids
    Mostafa Ghorab et al, 2016, Molecules CrossRef
13. Molecular Targeted Therapy for Breast Cancer: A New Frontiers
    Osama Al-Amer et al, 2017, Biosciences, Biotechnology Research Asia CrossRef
14. Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer
    Tomas Koltai et al, 2021, International Journal of Molecular Sciences CrossRef
15. Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation
    Yong-Seok Oh et al, 2017, Experimental & Molecular Medicine CrossRef
16. Integrin-Linked Kinase Links Integrin Activation to Invadopodia Function and Invasion via the p(T567)-Ezrin/NHERF1/NHE1 Pathway
    Maria Raffaella Greco et al, 2021, International Journal of Molecular Sciences CrossRef
17. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance
    J Vaquero et al, 2017, Oncogene CrossRef
18. RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)
    Chaido Sirinian et al, 2021, Genes CrossRef
19. Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer
    Zhaoyun Liu et al, 2017, PLOS ONE CrossRef
20. Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study
    Parham Jabbarzadeh Kaboli et al, 2019, Pharmacological Reports CrossRef
21. Cytoplasmic EBP50 and elevated PARP1 are unfavorable prognostic factors in ovarian clear cell carcinoma
    Toshihide Matsumoto et al, 2021, Carcinogenesis CrossRef
22. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells
    Tao Tao et al, 2017, International Journal of Molecular Sciences CrossRef
23. Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways
    Pablo Garrido et al, 2017, Oncotarget CrossRef